Free Trial

10 Best Small Cap Stocks to Buy Now - 1 of 10

 
 

Quince Therapeutics (NASDAQ:QNCX)

Consensus Rating
Strong Buy
Rating Score
3.5
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$8.50 (377.5% Upside)

About Quince Therapeutics

Quince Therapeutics logoQuince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/7/2024Maxim GroupInitiated CoverageBuy$6.00
10/29/2024RODMAN&RENSHAWUpgradeStrong-Buy
10/29/2024Rodman & RenshawInitiated CoverageBuy$11.00
10/22/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
 

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide